CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - Concepedia

Concepedia

Publication | Open Access

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

DOI Full Paper Access

230

Citations

53

References

2019

Year

Nicholas F. Kuhn, Terence J. Purdon, Dayenne G. van Leeuwen, Andrea V. Lopez, Kevin J. Curran, Anthony F. Daniyan, Renier J. Brentjens

Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyAntigen ProcessingImmunotherapyEndogenous Antitumor ResponseCell BiologyTumor Microenvironment

References

	Year	Citations

Page 1